(Q40640612)

22 September 2017

title

Adjuvant multiple drug chemotherapy for osteosarcoma of the extremity (English)

1 reference

10.1002/1097-0142(197701)39:1<51::AID-CNCR2820390110>3.0.CO;2-T

https://api.crossref.org/works/10.1002/1097-0142(197701)39:1%3C51::AID-CNCR2820390110%3E3.0.CO;2-T

2 March 2023

1 reference

10.1002/1097-0142(197701)39:1<51::AID-CNCR2820390110>3.0.CO;2-T

https://api.crossref.org/works/10.1002/1097-0142(197701)39:1%3C51::AID-CNCR2820390110%3E3.0.CO;2-T

2 March 2023

author name string

C. Pratt

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A299829

2 March 2023

E. Shanks

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A299829

2 March 2023

O. Hustu

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A299829

2 March 2023

G. Rivera

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A299829

2 March 2023

J. Smith

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A299829

2 March 2023

A. P. Kumar

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A299829

2 March 2023

language of work or name

English

0 references

publication date

1 January 1977

1 reference

full work available at URL

22 September 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2F1097-0142(197701)39:1%3C51::AID-CNCR2820390110%3E3.0.CO;2-T

1 reference

10.1002/1097-0142(197701)39:1<51::AID-CNCR2820390110>3.0.CO;2-T

https://api.crossref.org/works/10.1002/1097-0142(197701)39:1%3C51::AID-CNCR2820390110%3E3.0.CO;2-T

https://onlinelibrary.wiley.com/doi/full/10.1002/1097-0142(197701)39:1%3C51::AID-CNCR2820390110%3E3.0.CO;2-T

2 March 2023

1 reference

10.1002/1097-0142(197701)39:1<51::AID-CNCR2820390110>3.0.CO;2-T

https://api.crossref.org/works/10.1002/1097-0142(197701)39:1%3C51::AID-CNCR2820390110%3E3.0.CO;2-T

2 March 2023

1 reference

22 September 2017

volume

39

1 reference

22 September 2017

issue

1

1 reference

22 September 2017

page(s)

51-57

1 reference

The metastatic patterns of osteosarcoma

22 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%28197701%2939%3A1%3C51%3A%3AAID-CNCR2820390110%3E3.0.CO%3B2-T

High dose, preoperative supervoltage irradiation for osteogenic sarcoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%28197701%2939%3A1%3C51%3A%3AAID-CNCR2820390110%3E3.0.CO%3B2-T

Preoperative irradiation for osteogenic sarcoma

21 January 2018

1

1 reference

10.1002/1097-0142(197701)39:1<51::AID-CNCR2820390110>3.0.CO;2-T

https://api.crossref.org/works/10.1002/1097-0142(197701)39:1%3C51::AID-CNCR2820390110%3E3.0.CO;2-T

Doxorubicin in disseminated osteosarcoma

2 March 2023

2

1 reference

10.1002/1097-0142(197701)39:1<51::AID-CNCR2820390110>3.0.CO;2-T

https://api.crossref.org/works/10.1002/1097-0142(197701)39:1%3C51::AID-CNCR2820390110%3E3.0.CO;2-T

Amputation and Adriamycin in Primary Osteosarcoma

2 March 2023

3

1 reference

10.1002/1097-0142(197701)39:1<51::AID-CNCR2820390110>3.0.CO;2-T

https://api.crossref.org/works/10.1002/1097-0142(197701)39:1%3C51::AID-CNCR2820390110%3E3.0.CO;2-T

2 March 2023

7

27

2561

Djerassi

1967

1 reference

10.1002/1097-0142(197701)39:1<51::AID-CNCR2820390110>3.0.CO;2-T

https://api.crossref.org/works/10.1002/1097-0142(197701)39:1%3C51::AID-CNCR2820390110%3E3.0.CO;2-T

Phase I study of high doses of methotrexate with citrovorum factor in patients with lung cancer

2 March 2023

9

1 reference

10.1002/1097-0142(197701)39:1<51::AID-CNCR2820390110>3.0.CO;2-T

https://api.crossref.org/works/10.1002/1097-0142(197701)39:1%3C51::AID-CNCR2820390110%3E3.0.CO;2-T

The implications of "skip" metastases in osteosarcoma

2 March 2023

11

1 reference

10.1002/1097-0142(197701)39:1<51::AID-CNCR2820390110>3.0.CO;2-T

https://api.crossref.org/works/10.1002/1097-0142(197701)39:1%3C51::AID-CNCR2820390110%3E3.0.CO;2-T

New approaches to cancer chemotherapy with methotrexate

2 March 2023

13

1 reference

10.1002/1097-0142(197701)39:1<51::AID-CNCR2820390110>3.0.CO;2-T

https://api.crossref.org/works/10.1002/1097-0142(197701)39:1%3C51::AID-CNCR2820390110%3E3.0.CO;2-T

The therapy of osteogenic sarcoma: Current status and thoughts for the future

2 March 2023

14

1 reference

10.1002/1097-0142(197701)39:1<51::AID-CNCR2820390110>3.0.CO;2-T

https://api.crossref.org/works/10.1002/1097-0142(197701)39:1%3C51::AID-CNCR2820390110%3E3.0.CO;2-T

Methotrexate toxicity: Correlation with duration of administration, plasma levels, dose and excretion pattern

2 March 2023

15

1 reference

10.1002/1097-0142(197701)39:1<51::AID-CNCR2820390110>3.0.CO;2-T

https://api.crossref.org/works/10.1002/1097-0142(197701)39:1%3C51::AID-CNCR2820390110%3E3.0.CO;2-T

Current therapies in osteosarcoma

2 March 2023

16

1 reference

10.1002/1097-0142(197701)39:1<51::AID-CNCR2820390110>3.0.CO;2-T

https://api.crossref.org/works/10.1002/1097-0142(197701)39:1%3C51::AID-CNCR2820390110%3E3.0.CO;2-T

Recent advances in the chemotherapy of metastatic osteogenic sarcoma

2 March 2023

17

1 reference

10.1002/1097-0142(197701)39:1<51::AID-CNCR2820390110>3.0.CO;2-T

https://api.crossref.org/works/10.1002/1097-0142(197701)39:1%3C51::AID-CNCR2820390110%3E3.0.CO;2-T

The potential of combined modality approaches for the treatment of malignant bone tumors in children

2 March 2023

18

1 reference

10.1002/1097-0142(197701)39:1<51::AID-CNCR2820390110>3.0.CO;2-T

https://api.crossref.org/works/10.1002/1097-0142(197701)39:1%3C51::AID-CNCR2820390110%3E3.0.CO;2-T

Adjuvant methotrexate and citrovorum-factor treatment of osteogenic sarcoma

2 March 2023

20

1 reference

10.1002/1097-0142(197701)39:1<51::AID-CNCR2820390110>3.0.CO;2-T

https://api.crossref.org/works/10.1002/1097-0142(197701)39:1%3C51::AID-CNCR2820390110%3E3.0.CO;2-T

The New England Journal of Medicine

2 March 2023

21

292

433

Jaffe

1975

1 reference

10.1002/1097-0142(197701)39:1<51::AID-CNCR2820390110>3.0.CO;2-T

https://api.crossref.org/works/10.1002/1097-0142(197701)39:1%3C51::AID-CNCR2820390110%3E3.0.CO;2-T

OSTEOSARCOMA. A STUDY OF THE VALUE OF PREOPERATIVE MEGAVOLTAGE RADIOTHERAPY

2 March 2023

23

1 reference

10.1002/1097-0142(197701)39:1<51::AID-CNCR2820390110>3.0.CO;2-T

https://api.crossref.org/works/10.1002/1097-0142(197701)39:1%3C51::AID-CNCR2820390110%3E3.0.CO;2-T

A clinicopathologic analysis of adriamycin cardiotoxicity

2 March 2023

24

1 reference

10.1002/1097-0142(197701)39:1<51::AID-CNCR2820390110>3.0.CO;2-T

https://api.crossref.org/works/10.1002/1097-0142(197701)39:1%3C51::AID-CNCR2820390110%3E3.0.CO;2-T

Cyclophosphamide in children with cancer

2 March 2023

28

1 reference

10.1002/1097-0142(197701)39:1<51::AID-CNCR2820390110>3.0.CO;2-T

https://api.crossref.org/works/10.1002/1097-0142(197701)39:1%3C51::AID-CNCR2820390110%3E3.0.CO;2-T

2 March 2023

29

34

3326

Pratt

1974

1 reference

10.1002/1097-0142(197701)39:1<51::AID-CNCR2820390110>3.0.CO;2-T

https://api.crossref.org/works/10.1002/1097-0142(197701)39:1%3C51::AID-CNCR2820390110%3E3.0.CO;2-T

Letter: Hyperpigmentation of nails from doxorubicin

2 March 2023

31

1 reference

10.1002/1097-0142(197701)39:1<51::AID-CNCR2820390110>3.0.CO;2-T

https://api.crossref.org/works/10.1002/1097-0142(197701)39:1%3C51::AID-CNCR2820390110%3E3.0.CO;2-T

The Prognosis of Osteosarcoma: An Analytical Study

2 March 2023

33

1 reference

10.1002/1097-0142(197701)39:1<51::AID-CNCR2820390110>3.0.CO;2-T

https://api.crossref.org/works/10.1002/1097-0142(197701)39:1%3C51::AID-CNCR2820390110%3E3.0.CO;2-T

Adriamycin cardiotoxicity in man

2 March 2023

34

1 reference

10.1002/1097-0142(197701)39:1<51::AID-CNCR2820390110>3.0.CO;2-T

https://api.crossref.org/works/10.1002/1097-0142(197701)39:1%3C51::AID-CNCR2820390110%3E3.0.CO;2-T

High-dose methotrexate with citrovorum factor rescue and adriamycin in childhood osteogenic sarcoma

2 March 2023

36

1 reference

10.1002/1097-0142(197701)39:1<51::AID-CNCR2820390110>3.0.CO;2-T

https://api.crossref.org/works/10.1002/1097-0142(197701)39:1%3C51::AID-CNCR2820390110%3E3.0.CO;2-T

Chemotherapy,en bloc resection, and prosthetic bone replacement in the treatment of osteogenic sarcoma

2 March 2023

38

1 reference

10.1002/1097-0142(197701)39:1<51::AID-CNCR2820390110>3.0.CO;2-T

https://api.crossref.org/works/10.1002/1097-0142(197701)39:1%3C51::AID-CNCR2820390110%3E3.0.CO;2-T

Adriamycin--an antitumor antibiotic in the treatment of neoplastic diseases

2 March 2023

43

1 reference

10.1002/1097-0142(197701)39:1<51::AID-CNCR2820390110>3.0.CO;2-T

https://api.crossref.org/works/10.1002/1097-0142(197701)39:1%3C51::AID-CNCR2820390110%3E3.0.CO;2-T

Therapeutic effect and toxicity of adriamycin in patients with neoplastic disease

2 March 2023

44

1 reference

10.1002/1097-0142(197701)39:1<51::AID-CNCR2820390110>3.0.CO;2-T

https://api.crossref.org/works/10.1002/1097-0142(197701)39:1%3C51::AID-CNCR2820390110%3E3.0.CO;2-T

2 March 2023

Identifiers

10.1002/1097-0142(197701)39:1<51::AID-CNCR2820390110>3.0.CO;2-T

1 reference

22 September 2017

1 reference